HSP90B2P and neoplasm: The effective silencing of PKM2 was achieved both in vitro and in vivo, resulting in the inhibition of tumor glycolysis and the subsequent downregulation of HSP expression, overcoming the thermoresistance of tumor cells and enhancing ICG-mediated photothermal ablation [357].